Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Gregory Glenn
Age : 68
Public asset : 82,333 USD
Country of residence : Unknown
Linked companies : Novavax, Inc.

Biography of Gregory Glenn 
Gregory M. Glenn founded Intercell USA, Inc. Dr. Glenn is President-Research & Development at Novavax, Inc. He previously occupied the position of Chief Scientific Officer for Intercell AG, Chief Scientific Officer & Senior Vice President at Intercell USA, Inc., Research Scientist at Walter Reed Army Institute of Research and Associate-International Health at Johns Hopkins Bloomberg School of Public Health. Dr. Glenn received an undergraduate degree from Whitman College and a doctorate from Oral Roberts University.


Current positions of Gregory Glenn 
Holdings of Gregory Glenn 
Gregory Glenn : Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/26LVMH's Arnault brushes off succession question
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
02/02Billionaire Cohen builds stake in Nordstrom, urges board shakeup
RE
02/03Exclusive-BlackRock sustainability chief Bodnar to join Bezos Earth Fund - memo
RE
02/03U.S. jury finds Tesla and Musk not liable in case over take-private tweet
RE
02/03SoftBank Q3 seen under pressure from tech weakness, Arm IPO eyed
RE
02/01Sony Group CFO Totoki to succeed Yoshida as president - Nikkei
RE
01/31Italy considers replacements for Starace as Enel CEO, sources say
RE
More news


© 2023 People and Ownership :   
Gregory Glenn : Connections 


Latest news about Gregory Glenn 
2022Novavax Expects to Start Phase 2 Trial for Influenza-COVID-19 Combo Vaccine Candidate by 2022-end
MT
2022Novavax Says COVID-19 Booster Dose Produces 'Robust' Antibodies Against Omicron Variants
MT
2022Transcript : Novavax, Inc. Presents at Baird 2022 Global Healthcare Conference, Sep-13-2022 08:30 AM
CI
2022Transcript : Novavax, Inc. Presents at H.C. Wainwright 24th Annual Global Investment Conference, Sep-12-2022 04:00 PM
CI
2022Transcript : Novavax, Inc., Q2 2022 Earnings Call, Aug 08, 2022
CI
2022Transcript : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 05:20 PM
CI
2022Novavax Says Early COVID-Influenza Combo Vaccine Data 'Encouraging'
MT
More news